Details of the SBP
General Information of Synthetic Binding Protein (SBP) (ID: SBP003145) | ||||||
---|---|---|---|---|---|---|
SBP Name |
Nanobody anti-SARS-CoV-2 clone Ty1
|
|||||
Synonyms |
Nanobody Ty1
|
|||||
Molecular Weight | 12.8 kDa | |||||
Design Method | Traditional methods (Site-directed mutagenesis and/or Directed evolution) | |||||
Expression System | FreeStyle 293F cells | |||||
Selection Method | Phage display | |||||
Highest Status | Research | |||||
PDB ID | 6ZXN | |||||
Sequence Length | 128 | |||||
SBP Sequence |
>Nanobody anti-SARS-CoV-2 clone Ty1
MAQVQLVETGGGLVQPGGSLRLSCAASGFTFSSVYMNWVRQAPGKGPEWVSRISPNSGNI GYTDSVKGRFTISRDNAKNTLYLQMNNLKPEDTALYYCAIGLNLSSSSVRGQGTQVTVSS GGLPETGG |
|||||
3D Structure | ||||||
Experimentally Validated Structure | ||||||
Click to Save PDB File | ||||||
Template Name | Nb14 | |||||
Protein Scaffold Information of This SBP | ||||||
---|---|---|---|---|---|---|
Scaffold ID | PS048 | [1] | ||||
Scaffold Name | Nanobody | |||||
Scaffold Class | Antibody fragment | |||||
Fold Type | Beta-Sheets + Loops | |||||
Binding Target(s) of This SBP (BTS) |
---|
BTS Name | Details | Mechanism | Application | Affinity | Research Organization | Ref |
---|---|---|---|---|---|---|
Spike glycoprotein | Neutralizer | SARS-CoV-2 infection (COVID-19) [ICD-11: XN109] | Kd: 5-10 nM | Karolinska Institutet | [1] | |